Giacomo Corleone

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Challenges and advances in drug resistance and tolerance in cancer.

Challenges and advances in drug resistance and tolerance in cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 21, 2026

Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer.

Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 05, 2025

T-ChroNet: Time-aware chromatin network reconstruction to detect dynamic regulatory programs in longitudinal epigenetic dataset.

T-ChroNet: Time-aware chromatin network reconstruction to detect dynamic regulatory programs in longitudinal epigenetic dataset.

Journal: NAR genomics and bioinformatics

Published: August 12, 2025

p63 and ZNF148 cooperate to regulate head and neck squamous cell carcinoma.

p63 and ZNF148 cooperate to regulate head and neck squamous cell carcinoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 07, 2025

HBV-driven host chromatin accessibility changes affect liver metabolic pathways, iron homeostasis and promote a preneoplastic phenotype.

HBV-driven host chromatin accessibility changes affect liver metabolic pathways, iron homeostasis and promote a preneoplastic phenotype.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 03, 2025

Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.

Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.

Journal: Blood

Published: January 21, 2025

Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.

Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.

Journal: Nature immunology

Published: September 17, 2024

Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia.

Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 11, 2024

WTAP and m6A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells.

WTAP and m6A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells.

Journal: Cellular and molecular life sciences : CMLS

Published: March 23, 2024

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.

Journal: Journal for immunotherapy of cancer

Published: August 08, 2023

Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.

Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.

Journal: Leukemia

Published: June 14, 2023

Dissecting the Epigenome Driving Drug Resistance by ATAC-Seq.

Dissecting the Epigenome Driving Drug Resistance by ATAC-Seq.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 22, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026